122 related articles for article (PubMed ID: 37661831)
21. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.
Issaka RB; Bell-Brown A; Snyder C; Atkins DL; Chew L; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
JAMA Netw Open; 2021 Aug; 4(8):e2120159. PubMed ID: 34374771
[TBL] [Abstract][Full Text] [Related]
22. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
[TBL] [Abstract][Full Text] [Related]
23. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
24. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
[TBL] [Abstract][Full Text] [Related]
25. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
[TBL] [Abstract][Full Text] [Related]
26. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
[TBL] [Abstract][Full Text] [Related]
27. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
[TBL] [Abstract][Full Text] [Related]
28. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve three-year adherence to colorectal cancer screening among patients cared for in rural community health centers.
Davis TC; Morris JD; Reed EH; Curtis LM; Wolf MS; Davis AB; Arnold CL
Contemp Clin Trials; 2022 Feb; 113():106654. PubMed ID: 34906745
[TBL] [Abstract][Full Text] [Related]
29. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
31. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
32. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
33. Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.
Tran CT; Nguyen MV; Tran MT; Tuong TT; Tran QH; Le LC; Pham HT; Bui NC; Vu HH; Nguyen TT; Ta PQ; Ha HT; Trinh DT; Bui HT; Trinh DQ; Van Nguyen K; Le SH; Van Vu K; Van Tran T; Tran HT; Shrubsole MJ; Ye F; Cai Q; Zheng W; Boffetta P; Shu XO; Luu HN
Jpn J Clin Oncol; 2022 Jul; 52(7):707-715. PubMed ID: 35383373
[TBL] [Abstract][Full Text] [Related]
34. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.
Corley DA; Jensen CD; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Schottinger JE; Marks AR; Zhao WK; Ghai NR; Lee AT; Contreras R; Quesenberry CP; Fireman BH; Levin TR
JAMA; 2017 Apr; 317(16):1631-1641. PubMed ID: 28444278
[TBL] [Abstract][Full Text] [Related]
35. A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial.
Christy SM; Sutton SK; Abdulla R; Boxtha C; Gonzalez P; Cousin L; Ewing A; Montoya S; Lopez D; Beehler T; Sanchez J; Carvajal R; Meade CD; Gwede CK
Prev Med; 2022 May; 158():107021. PubMed ID: 35305995
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
39. Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.
Levy BT; Bay C; Xu Y; Daly JM; Bergus G; Dunkelberg J; Moss C
J Med Screen; 2014 Sep; 21(3):133-43. PubMed ID: 24958730
[TBL] [Abstract][Full Text] [Related]
40. Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case-Control Study.
Kim SY; Kim HS; Kim YT; Lee JK; Park HJ; Kim HM; Kang DR
Clin Transl Gastroenterol; 2021 Apr; 12(5):e00350. PubMed ID: 33928919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
